Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference8 articles.
1. Spiegel, R. Aspirin as a painkiller in patients with a high cardiovascular risk profile. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-020-0398-4 (2020).
2. Schjerning, A. M., McGettigan, P. & Gislason, G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat. Rev. Cardiol. https://doi.org/10.1038/s41569-020-0366-z (2020).
3. NHS Digital. Prescription cost analysis – England, 2018 [PAS]. NHS Digital https://digital.nhs.uk/data-and-information/publications/statistical/prescription-cost-analysis/2018 (2019).
4. Forder, S., Voelker, M. & Lanas, A. Gastrointestinal safety of aspirin for a high-dose, multiple-day treatment regimen: a meta-analysis of three randomized controlled trials. Drugs R D 16, 263–269 (2016).
5. Huang, E. S., Strate, L. L., Ho, W. W., Lee, S. S. & Chan, A. T. Long-term use of aspirin and the risk of gastrointestinal bleeding. Am. J. Med. 124, 426–433 (2011).